Registration - Amendment

SIDLEY AUSTIN LLP for MEDICAL INFORMATION WORKING GROUP

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

DOJ policy regarding off label communications

LobbyistCovered position, as disclosed
PAUL E. KALB New N/A

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ROCHE HOLDINGS AG Switzerland Switzerland — —
GLAXOSMITHKLINE, PLC United Kingdom United Kingdom — —
BAYER AG Germany Germany — —
ALLERGAN PLC Ireland Ireland — —
BOEHRINGER INGELHEIM INTERNATIONAL GMBH Germany Germany — —
NOVARTIS AG Switzerland Switzerland — —
SANOFI-AVENTIS SA France France — —

Affiliated organisations

OrganisationLocation
AMGEN INC. Washington, DC, US
BAYER HEALTHCARE PHARMACEUTICALS INC. Whippany, NJ, US
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. Ridgefield, CT, US
BRISTOL-MYERS SQUIBB COMPANY New York, NY, US
ELI LILLY AND COMPANY Indianapolis, IN, US
GENENTECH, INC. South San Francisco, CA, US
GLAXOSMITHKLINE LLC Philadelphia, PA, US
JOHNSON & JOHNSON SERVICES New Brunswick, NJ, US
NOVARTIS PHARMACEUTICAL CORPORATION East Hanover, NJ, US
PFIZER, INC. New York, NY, US
SAMUMED, LLC San Diego, CA, US
SANOFI US SERVICES INC. Bridgewater, NJ, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.